Diseases [C] » Cardiovascular Diseases
Description
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. MeSH
Hierarchy View
Subtype Terms (5)
Cardiovascular Abnormalities
25 drugs (17 approved, 8 experimental)
Heart Diseases
402 drugs (259 approved, 143 experimental)
Vascular Diseases
191 drugs (133 approved, 58 experimental)
Approved Indicated Drugs (31)
Phase 2 Indicated Drugs (56)
Other Experimental Indicated Drugs (142)
Organization Involved with Phase 4 Indications (222)
Acerus Pharmaceuticals Corporation
American College of Rheumatology Research and Education Foundation
ANMCO Italian Association of Hospital Cardiologist
Applied Health Research Centre
Associazione Medici Diabetologi (AMD)
Associazione Nazionale Medici Cardiologi Ospedalieri
Canadian Institutes of Health Research (CIHR)
Canadian Medical and Surgical Knowledge Translation Research Group
Canadian Network and Centre for Trials Internationally
CardioVascular Research Foundation, Korea
COLM Study Research Organization
Daewoong Pharmaceutical Co. LTD.
Dutch Diabetes Research Foundation
Father Sean O'Sullivan Research Centre
Federal University of Health Science of Porto Alegre
Federal University of Rio Grande do Sul
Fundação de Amparo à Pesquisa do Estado de São Paulo
Garvan Institute of Medical Research
Hamilton Health Sciences Corporation
Heart and Stroke Foundation of Canada
Helena Laboratories Point of Care
Hospital Alessandro Manzoni Lecco
Hospital Italiano de Buenos Aires
Hospital Regional 10 de Octubre, ISSSTE
Hospital Universitario Arnau de Vilanova de Lleida
Icahn School of Medicine at Mount Sinai
Imam Abdulrahman Bin Faisal University
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Italian Society of Diabetology
Italian Society of Invasive Cardiology
Japan Foundation for Aging and Health
King Fahad Armed Forces Hospital
Lepu Medical Technology (Beijing) Co., Ltd.
Les Laboratoires des Médicaments Stériles
Nang Kuang Pharmaceutical Co., Ltd.
National Cheng Kung University
National Heart Foundation, Australia
National Heart, Lung, and Blood Institute (NHLBI)
National Institute for Health Research, United Kingdom
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Aging (NIA)
National Institutes of Health (NIH)
People's Liberation Army of China
Research Maatschap Cardiologen Rotterdam Zuid
Royal College of Surgeons, Ireland
Rundo International Pharmaceutical Research & Development Co.,Ltd.
Samjin Pharmaceutical Co., Ltd.
Steno Diabetes Center Copenhagen
St. Marianna University School of Medicine
The Japanese Society of Hypertension
The Massachusetts Mental Health Center
The National Centre in HIV Epidemiology and Clinical Research, Sydney
The Physicians' Services Incorporated Foundation
The University of Texas, Dallas
Thrombolysis In Myocardial Infarction Academic Research Organization
Universidad Complutense de Madrid
Universidade Estadual de Londrina
University of California, Los Angeles
University of California, San Francisco
University of Erlangen-Nuremberg
University of Modena and Reggio Emilia
University of Naples Frederico II
University of North Carolina at Chapel Hill
University of Roma La Sapienza
University of Southern California
University of Texas at Houston
University of Texas, San Antonio
University of Western Australia
Virginia Commonwealth University
Organization Involved with Phase 3 Indications (212)
Azienda Ospedaliera San Gerardo di Monza
Boston Health and Hospitals Department
Case Western Reserve University
Catholic University of Sacred Heart, Rome
Centers for Disease Control and Prevention (CDC)
Centre d'Atenció Primaria Bon Pastor
Centro de Atención Primaria Alcover, Tarragona (Spain)
Chinese University of Hong Kong
CIHR Canadian HIV Trials Network
Clinical Trials & Surveys Corp
East Kent Hospitals University NHS Foundation Trust
Epsom and St Helier University Hospitals NHS Trust
Fédération francaise de cardiologie
Fondazione Mediolanum per Attività e Ricerche Cardiovascolari Onlus
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Golestan University of Medical Science
Gottfried Wilhelm Leibniz Universität Hannover
Greater Baltimore Medical Center
Hospital Saint Franciscus Gasthuis, Rotterdam
Instituto de Ensino e Pesquisa - IEP - HCor
Jiangsu Carefree Pharmaceutical Co., Ltd.
Kennedy-Leigh charitable trust
Maryland Medical Research Institute
Mauritius Ministry of Health and Quality of Life
Moorgreen Hospital, Southampton
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Health and Medical Research Council, Australia
National Institute of Neurological Disorders and Stroke (NINDS)
Office of Dietary Supplements (ODS)
Oklahoma Medical Research Foundation
Oregon Health and Science University
Pacific Health Research Institute
Palo Alto Medical Research Foundation
Public Health Foundation of India
Russian Academy of Medical Sciences
Salt Lake Clinic Research Foundation
Societe Uniniere de Bois Cheri
Statistics and Epidemiology Research Corporation
St. Joseph Hospital Health Center
Universidad Autonoma de Barcelona
University of Alabama, Birmingham
University of California, Berkeley
University of California, Davis
University of California, San Diego
University of Colorado, Denver
University of Medicine and Dentistry of New Jersey
Vita-Salute University of Milano. Italy
Washington University in St. Louis
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 2 Indications (73)
Agri-Food Research and Development Initiative
Albany College of Pharmacy and Health Sciences
Fundacion Investigacion y Desarrollo
Hoosier Cancer Research Network
Medical University of South Carolina
National Hospital of Sri Lanka
National Institute of Mental Health (NIMH)
National Institute on Drug Abuse (NIDA)
Organization Involved with Phase 1 Indications (39)
Organization Involved with Other Experimental Indications (151)
Albert Einstein Israelite Hospital
Alliance for Potato Research and Education
Azienda Provinciale per i Servizi Sanitari della Provincia Autonoma di Trento
Biotechnology and Biological Sciences Research Council
California Healthcare Institute
California Strawberry Commission
Central Jutland Regional Hospital
Centro de Estudios en Alimentos Procesados
Centro Tecnológico de Nutrición y Salud (Eurecat_Reus). Reus, Tarragona, Spain.
Chicago Area Patient Centered Outcomes Research Network
Clinical Hospital Center Zemun
Department of Health, United Kingdom
Dutch Foundation for alcohol research
European Foundation for the Study of Diabetes
German Federal Ministry of Education and Research
Greater Plains Collaborative Clinical Data Research Network
HealthCore-Anthem Research Network
Hormozgan University of Medical Sciences
Huazhong University of Science and Technology
I.M. Sechenov First Moscow State Medical University
Institut Hospital del Mar d'Investigacions Mèdiques
Klinički Bolnički Centar Zagreb
Liverpool John Moores University
Mid-South Clinical Data Research Network
National Center for Research Resources (NCRR)
National Science Centre, Poland
Natraceutical Industrial S.L.U.
New York City Clinical Data Research Network
PaTH Clinical Data Research Network
Pharmactive Biotech Products S.L.
Prostate Cancer Canada Network
Rajiv Gandhi University of Health Sciences
Research Action for Health Network
Technical University of Denmark
The Government Pharmaceutical Organization
The Hong Kong Society of Nephrology
The Regional Centre for Studies in Food and Health (CREAS), Valparaíso, Chile
Tomato Products Wellness Council
Ubonratchathani Cancer Hospital
Universidad Autonoma de Ciudad Juarez
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
